Ipca Laboratories Ltd (IPCALAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 950228, "name": "Ipca Labs", "stock_name": "Ipca Labs", "full_name": "Ipca Laboratories Ltd", "name_url": "stocks-analysis/ipca-labs", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,479.60", "chg": -31.35, "chgp": "-2.07%", "dir": -1, "prev_price": "1,510.95", "mcapval": "36,711.00 Cr", "mcap": "Mid Cap", "scripcode": "524494", "symbol": "IPCALAB", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE571A01038", "curr_date": "Apr 02", "curr_time": "", "bse_nse_vol": "2.15 lacs", "exc_status": "Active", "traded_date": "Apr 02, 2026", "traded_date_str": "2026 04 02", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ipca-labs-950228-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Ipca Laboratories Ltd Downgraded to Hold Amid Valuation and Technical Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-ltd-downgraded-to-hold-amid-valuation-and-technical-concerns-3929650", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IpcaLaboratorie_mojoScore_3929650.png", "date": "2026-04-02 08:22:44", "description": "Ipca Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 1 April 2026. This adjustment reflects a nuanced shift across four critical parameters: quality, valuation, financial trend, and technical indicators. Despite strong long-term returns and solid financial performance, evolving market dynamics and valuation concerns have tempered investor enthusiasm." }, { "title": "Ipca Laboratories Ltd Hits Intraday Low Amid Price Pressure on 1 April 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-hits-intraday-low-amid-price-pressure-on-1-april-2026-3929305", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IpcaLaboratorie_priceRelatedfactors_3929305.png", "date": "2026-04-01 14:46:01", "description": "Ipca Laboratories Ltd experienced a notable intraday decline on 1 Apr 2026, touching a low of Rs 1,514.1, down 5.55% from its previous close. The stock underperformed its sector and broader market indices, reflecting immediate selling pressure and a shift in market sentiment." }, { "title": "Ipca Laboratories Upgraded to Buy on Strong Technicals and Financial Performance", "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-upgraded-to-buy-on-strong-technicals-and-financial-performance-3923525", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_mojoScore_3923525.png", "date": "2026-03-30 08:07:16", "description": "Ipca Laboratories Ltd has seen its investment rating upgraded from Hold to Buy, reflecting improvements across technical indicators, valuation metrics, financial trends, and overall quality. The pharmaceutical company’s robust quarterly results, consistent returns, and positive market momentum have contributed to this enhanced outlook, despite a valuation that now classifies it as very expensive relative to peers." }, { "title": "Ipca Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-3923433", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_technicaldot_3923433.png", "date": "2026-03-30 08:02:23", "description": "Ipca Laboratories Ltd has demonstrated a notable shift in technical momentum, with key indicators signalling a transition from mildly bullish to a more confident bullish stance. This change is underscored by improvements in moving averages, Bollinger Bands, and MACD readings, suggesting growing investor confidence amid a strong price performance that outpaces the broader market." }, { "title": "Ipca Laboratories Ltd Valuation Shifts Signal Changing Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-valuation-shifts-signal-changing-price-attractiveness-3923354", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_valuationdot_3923354.png", "date": "2026-03-30 08:01:38", "description": "Ipca Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, reflecting evolving market perceptions and price attractiveness. Despite this, the company’s robust financial performance and strong returns relative to the Sensex continue to underpin its Buy-grade status, signalling confidence among investors in the Pharmaceuticals & Biotechnology sector." }, { "title": "Ipca Laboratories Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-ltd-is-rated-buy-3922732", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_mojoScore_3922732.png", "date": "2026-03-29 10:10:26", "description": "Ipca Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 27 March 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 29 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Ipca Laboratories Ltd Dips 0.89%: 3 Key Factors Behind the Week’s Mixed Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-dips-089-3-key-factors-behind-the-weeks-mixed-momentum-3905305", "imagepath": "", "date": "2026-03-21 15:00:06", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>16 Mar:</strong> Stock opens at Rs.1,555.20, dips 0.36%</p>\n <p><strong>17 Mar:</strong> New 52-week high at Rs.1,624; technical momentum shifts mildly bullish</p>\n <p><strong>18 Mar:</strong> Downgrade to Hold rating amid valuation and technical concerns</p>\n <p><strong>20 Mar:</strong> Week closes at Rs.1,546.95, down 0.89% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,560.80</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class..." }, { "title": "Ipca Laboratories Ltd Downgraded to Hold Amid Valuation and Technical Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-ltd-downgraded-to-hold-amid-valuation-and-technical-concerns-3898089", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_mojoScore_3898089.png", "date": "2026-03-18 08:08:55", "description": "Ipca Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold by MarketsMOJO as of 17 March 2026. This revision reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite strong long-term returns and solid financials, evolving market dynamics and valuation pressures have prompted a more cautious stance." }, { "title": "Ipca Laboratories Ltd Hits New 52-Week High at Rs.1624", "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-hits-new-52-week-high-at-rs1624-3896579", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_priceRelatedfactors_3896579.png", "date": "2026-03-17 11:24:29", "description": "Ipca Laboratories Ltd has reached a significant milestone by hitting a new 52-week high of Rs.1624 today, marking a notable surge in its stock price and reflecting strong momentum within the Pharmaceuticals & Biotechnology sector." } ], "total": 935, "sid": "950228", "stock_news_url": "https://www.marketsmojo.com/news/ipca-laboratories-950228" }, "announcements": [ { "caption": "Closure of Trading Window", "datetime": "16-Mar-2026", "details": "Closure of Trading Window", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome", "datetime": "18-Feb-2026", "details": "Transcript of Conference Call held on 16.02.2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "16-Feb-2026", "details": "Copy of Newspaper Publication", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Ipca Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 05 Aug 25", "dt": "2025-08-05", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Ipca Laboratories Ltd has announced <strong>1:2</strong> stock split, ex-date: 10 Jan 22", "dt": "2022-01-10", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

16 Mar: Stock opens at Rs.1,555.20, dips 0.36%

17 Mar: New 52-week high at Rs.1,624; technical momentum shifts mildly bullish

18 Mar: Downgrade to Hold rating amid valuation and technical concerns

20 Mar: Week closes at Rs.1,546.95, down 0.89% for the week

Week Open

Rs.1,560.80

Week Close

Read full news article

Ipca Laboratories Ltd Downgraded to Hold Amid Valuation and Technical Concerns

2026-03-18 08:08:55

Ipca Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold by MarketsMOJO as of 17 March 2026. This revision reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite strong long-term returns and solid financials, evolving market dynamics and valuation pressures have prompted a more cautious stance.

Read full news article

Ipca Laboratories Ltd Hits New 52-Week High at Rs.1624

2026-03-17 11:24:29

Ipca Laboratories Ltd has reached a significant milestone by hitting a new 52-week high of Rs.1624 today, marking a notable surge in its stock price and reflecting strong momentum within the Pharmaceuticals & Biotechnology sector.

Read full news article